维普中文期刊产品整合服务
689篇 您的检索式:作者名="Tulandi"
    题名 作者 年代 出处 被引量
1Prospective randomized double-blind trial of the correlation between time of administration and antiestrogenic effects of clomiphene citrate on reproductive end organs显示文摘Marinko M Biljan Neal G Mahutte Togas Tulandi Seang Lin Tan 1999Fertility and Sterility1999,,4:2
2来曲唑或克罗米芬治疗不孕后怀孕的911例新生儿中的先天性畸形分析显示文摘Objective: To evaluate the incidence of congenital malformations among offspring of mothers who conceived with clomiphene citrate(CC) or with letrozole treatment for infertility. Design: Retrospective study. Setting: 5 fertility centers in Canada. Patients: 911 newborns from women who conceived following CC or letrozole treatment. Interventions: Examination of medical files of both mother and newborn, and cross-checked with the parents by telephone calls. Main Outcome Measures: Identified major and minor congenital malformations, birth weight, age of the mother, and type of treatment that led to the conception. Results: Overall, congenital malformations and chromosomal abnormalities were found in 14 of 514 newborns in the letrozole group(2.4%) and in 19 of 397 newborns in the CC group(4.8%). The major malformation rate in the letrozole group was 1.2%(6/514) and in the CC group was 3.0%(12/397). One newborn in the letrozole group was found to have a ventricular septal defect(0.2%)-compared to 4 newborns in the CC group(1.0%). In addition, the rate of all congenital cardiac anomalies was significantly higher(P: 0.02) in the CC group(1.8%) compared to the letrozole group(0.2%). Conclusion: There was no difference in the overall rates of major and minor congenital malformations among newborns from mothers who conceived after letrozole or CC treatments. However, it appears that congenital cardiac anomaly is less frequent in the letrozole group. The concern that letrozole use for ovulation induction could be teratogenic is unfounded based on our data.Tulandi T. Martin J. Al-Fadhli R. R.F. Casper 李跃萍 2006世界核心医学期刊文摘(妇产科学分册)2006,0,10:2
3子宫肌瘤栓塞失败的分析显示文摘Objective: To assess the outcomes of patients who underwent uterine fibroid embolization (UFE) and to evaluate factors associated with failure of UFE. Design: Retrospective study. Setting: University teaching hospital. Patient(s): Two hundred thirty-three consecutive patients who underwent UFE from November 1997 to February 2004. Intervention(s): Uterine fibroid embolizations were performed by three interventional radiologists using 355-500-μpolyvinyl alcohol particles. Main Outcome Measure(s): Hysterectomy rate, myomectomy rate, and repeat UFE rate. Result(s): With a mean follow-up of 13 months, a total of 22 patients underwent surgery after UFE (9.4%); 16 had hysterectomies (6.9%), and 6 had myomectomies (2.6%). This included 3 patients who underwent repeat UFE and subsequently required surgical intervention. The mean (±SEM) time interval between UFE and subsequent treatment was 12.5 ±2.0 months. Among patients who required surgery, 13 (59.1%) presented with recurrent menorrhagia, and 5 (22.7%) complained of persistent abdominal pain. Histopathologic examination revelead concomitant findings of adenomyosis in 25%of hysterectomy specimens. Patients who failed UFE were more likely to have had a previous myomectomy (13%vs 2.4%) and significant reduction in the uterine size 6 months after UFE (57.1%vs 25.2%). Conclusion(s): The overall failure rate of UFE is 9.4%. Failure is mainly due to persistent menorrhagia and abdominal pain. Shrinkage of the uterus after UFE does not necessarily correlate with long-term success of UFE.Huang J.Y.J. Kafy S. Dugas A. T. Tulandi 李跃萍 2006世界核心医学期刊文摘(妇产科学分册)2006,0,4:2
4Prospective randomized study of human chorionic gonadotrophin priming befor immature oocyte retrieval from unstimulated women with polycystic ovarian syndrome显示文摘 Buckett WM Tulandi T 2000Hum Reorod2000,15,1:1
5Endoscopic management of uterine fibroids显示文摘Agdi M Tulandi T 2008Best Pract Res Clin Obstet Gynaecol2008,22,4:1
6Prospective randomized study of human chorionic gonadotrophin priming before immature oocyte retrieval from unstimulated women with polycystic ovarian syndrome显示文摘Chain RC Buckett WM Tulandi T 2000Hum Reprod2000,15,1:1
7Minimally invasive approach for myomectomy显示文摘Agdi M Tulandi T 0,,03:1
8Serum vascular endothelial growth factor as a possible marker for early ectopic pregnancy显示文摘Felemban A Sammour A Tulandi T 2002Hum Reprod2002,17,2:1
9Surgical treatment of ectopic pregnan- cy显示文摘Al - Sunaidi M Tulandi T 2007Semiin Reprod Med2007,25,2:1
10Closure of laparotomy incisions with or without peritoneal suturing and second-look laparoscopy显示文摘Tulandi T Ham HS Gelfand MM 1988Am J Obstet Gynecol1988,158,31:1
11Images in endoscopy: retained fetal bones in the uterine cavity 显示文摘TULANDI T 2001J Am Assoc Gynecol Laparoc2001,8,:1
12Operative laparoscopy:surgical modalities显示文摘Tulandi T Bugnah M 1995Fertil Steril1995,63,2:1
13Endoscopic myomectomy:laparoscopy and hystemscopy显示文摘Tulandi T Took S 2010Obstet Gynecol Clin North Am2010,22,36:1
14Conservative medical and surgical management of interstitial ectopic pregnancy显示文摘LAU S TULANDI T 1999Fertil Steril1999,72,2:1
15Reproductive performance after selective tubal catheterization显示文摘Al-Jaroudi D Herba M J Tulandi TJ 2005Minim Invas Gynecol2005,12,2:1
16Effects of fibrin sealant on tubal anastomosis and adhesion formation显示文摘Tulandi T 0,,01:1
17The use of barbed suture in hys- terectomy and myomectomy:a systematic review and meta-analysis 显示文摘TULANDI T EINARSSON JI 2014J Minim Invasive Gynecol2014,21,2:1
18Current status of surgical and nonsurgical management of ectopic pregnancy显示文摘 Tulandi T 1997Fertil steril1997,67,3:1
19Serum vascular endothelial growth factor as a possible marker for early ectopic pregnancy 显示文摘Felemban A Sammour A Tulandi T 2002Hum Reprod2002,17,2:1
20Prospective randomized study of human chofionic gonadotrophin priming polycysfic ovarian syndrome显示文摘Chian R C Buckett W M Tulandi T 2000Hum Reprod2000,15,1:1
返回顶部 每页显示:
共35页 首页 上一页 第1页 下一页 末页 /35 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费